Cancer Research Cancer Research Funding Available  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 57, 5579-5583, December 15, 1997]
© 1997 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Misao, R.
Right arrow Articles by Tamaya, T.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Misao, R.
Right arrow Articles by Tamaya, T.

Expression of Sex Hormone-binding Globulin Exon VII Splicing Variant Messenger RNA in Human Uterine Endometrial Cancers

Ryou Misao1, Yoshihito Nakanishi, Jiro Fujimoto and Teruhiko Tamaya

Department of Obstetrics and Gynecology, Gifu University School of Medicine, Gifu 500, Japan

We have demonstrated the intracellular expression of sex hormone-binding globulin (SHBG) exon VII splicing variant mRNA in human uterine endometrial cancer using the reverse transcription-PCR-Southern blot and DNA sequencing analyses. Analysis of the missing base pairs proved that they corresponded to the entire exon VII, which is considered to encode a portion of the steroid-binding site, suggesting that the steroid-binding affinity of this variant might be different from that of the SHBG wild type. In uterine endometrial cancers, the wild-type mRNA levels significantly (P < 0.01) decreased, and the ratio of the SHBG variant to wild-type mRNA levels (P < 0.01) increased with the advance of histological dedifferentiation. These results suggest that dedifferentiation of endometrial cancers might induce a reduction in their estrogen-dependent properties via intracellular SHBG.

1 To whom requests for reprints should be addressed, at Department of Obstetrics and Gynecology, Gifu University School of Medicine, 40 Tsukasa-machi, Gifu 500, Japan. Phone: 81 58-267-2631; Fax: 81 58-265-9006.

Received 5/13/97. Accepted 10/15/97.




This article has been cited by other articles:


Home page
Cancer Res.Home page
J. P. Venables
Aberrant and Alternative Splicing in Cancer
Cancer Res., November 1, 2004; 64(21): 7647 - 7654.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. M. Selva, K. N. Hogeveen, K. Seguchi, F. Tekpetey, and G. L. Hammond
A Human Sex Hormone-binding Globulin Isoform Accumulates in the Acrosome during Spermatogenesis
J. Biol. Chem., November 15, 2002; 277(47): 45291 - 45298.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
F. Munell, C. A. Suarez-Quian, D. M. Selva, O. M. Tirado, and J. Reventos
Androgen-Binding Protein and Reproduction: Where Do We Stand?
J Androl, September 1, 2002; 23(5): 598 - 609.
[Full Text] [PDF]


Home page
EndocrinologyHome page
M. Jänne, K. N. Hogeveen, H. K. Deol, and G. L. Hammond
Expression and Regulation of Human Sex Hormone-Binding Globulin Transgenes in Mice during Development
Endocrinology, September 1, 1999; 140(9): 4166 - 4174.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1997 by the American Association for Cancer Research.